Systematic review of single‑port vs. multi‑port surgery for rectal cancer | Zendy

Mitsuyoshi Tei | Zendy; Toshinori Sueda | Zendy; Tae Matsumura | Zendy; H Furukawa | Zendy; Chikato Koga | Zendy; Masaki Wakasugi | Zendy; Hiromichi Miyagaki | Zendy; Ryohei Kawabata | Zendy; Masanori Tsujie | Zendy; Junichi Hasegawa | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Systematic review of single‑port vs. multi‑port surgery for rectal cancer

Author(s) -

Mitsuyoshi Tei,

Toshinori Sueda,

Tae Matsumura,

H Furukawa,

Chikato Koga,

Masaki Wakasugi,

Hiromichi Miyagaki,

Ryohei Kawabata,

Masanori Tsujie,

Junichi Hasegawa

Publication year - 2020

Publication title -

molecular and clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.442

H-Index - 7

eISSN - 2049-9469

pISSN - 2049-9450

DOI - 10.3892/mco.2020.2186

Subject(s) - medicine , colorectal cancer , cochrane library , port (circuit theory) , randomized controlled trial , cancer , surgery , electrical engineering , engineering

The aim of the current systematic review was to compare the short-term clinical and oncological outcomes of single-port surgery (SPS) to multi-port surgery (MPS) for rectal cancer in MEDLINE, PubMed and Cochrane Library from January 2010 to December 2018. A total of 5 clinical controlled studies composed one randomized pilot study and four non-randomized studies with a total of 461 patients were analyzed after a systematic review. A total of 125 patients (27.1%) underwent SPS and 336 patients (72.9%) underwent MPS for rectal cancer. The rate of conversion to open surgery was lower in the SPS group compared with the MPS group (0.8 vs. 5.4%, respectively). A total of 16.8% of patients in the SPS group required an additional port to complete the operation. The morbidity rate was lower in the SPS group compared with the MPS group (28.0 vs. 39.0%, respectively). The other short-term clinical outcomes were similar in both groups. The R0 resection rate was 99.0% in the SPS group and 98.7% in the MPS group. The oncological clearance was satisfactory and similar in both groups. The current study concluded that SPS can be performed safely and provide satisfactory oncological outcomes in patients with rectal cancer. However, further studies are required to determine the role of SPS in the long-term clinical and oncological outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research